1. Introduction {#sec1}
===============

Establishment of β-cell mass is largely dictated during the embryonic and neonatal stages [@bib1], [@bib2], [@bib3]. In the embryo, new β-cells are formed by differentiation of pancreatic endocrine precursors, followed by proliferation of differentiated β-cells [@bib3], [@bib4], [@bib5]. After birth, the major route of β-cell generation is their replication [@bib1], [@bib6], [@bib7]. However, β-cell proliferation rates decline with age in both humans and rodents and are significantly higher during the neonatal period than during adulthood [@bib2], [@bib3], [@bib8], [@bib9], [@bib10]. In humans, proliferation of β-cells begins shortly after birth, continues at its highest rate for about a year, and then rapidly declines in early childhood [@bib2], [@bib9]. In rodents, the β-cell proliferation rate peaks during the first week of life, and rapidly declines shortly thereafter [@bib3], [@bib8]. A further decline in β-cell proliferation rates is observed as humans and rodents age, when the proliferation index of these cells approaches zero during adulthood [@bib2], [@bib3], [@bib9], [@bib11]. However, adult β-cells maintain an ability for compensatory proliferation in response to increased metabolic demand or injury [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19].

β-cells respond to cues provided by cells of their microenvironment, in which endothelial, neuronal, and immune cells have been shown to promote adult β-cell proliferation [@bib20], [@bib21], [@bib22], [@bib23], [@bib24]. In addition to endothelial cells, the dense capillary network of islets contains pericytes, which form a single discontinuous layer around smaller vessels and are intimately associated with endothelial cells [@bib25]. Interactions between endothelial cells and pericytes are required for assembling the vascular basement membrane (BM) [@bib26], [@bib27], which, in the islet, was shown to support β-cell proliferation and function [@bib20], [@bib28]. Together with vascular smooth muscle cells (vSMCs), which surround large blood vessels, pericytes constitute a class of mesenchymal cells termed 'mural cells' [@bib27]. The embryonic pancreatic mesenchyme was shown by us and others to support the proliferation of pancreatic progenitors and differentiated β-cells [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35]. After birth, pericytes constitute a major part of the mesenchymal cell population in the pancreas [@bib25], [@bib36]. However, the role of pancreatic pericytes in postnatal β-cell proliferation awaits investigation.

Here, we investigated the ability of neonatal pancreatic pericytes to promote β-cell proliferation both *in vitro* and *in vivo*. Our findings indicate that the conditioned medium of cultured neonatal pericytes stimulates the proliferation of both a β-cell tumor line, βTC-tet [@bib37], and primary cultured adult β-cells. Furthermore, pericyte-conditioned medium induced β-cell expansion in an integrin β1-dependent manner, implicating the involvement of BM components in this process. Lastly, we used iDTR (inducible diphtheria toxin \[DT\] receptor) [@bib38] and *Nkx3.2*-Cre [@bib33], [@bib39] mouse lines to target and deplete pericytes in the neonatal pancreas and analyzed the resulting effect on β-cell proliferation. We show that partial pericyte depletion was sufficient to reduce the rate of neonatal β-cell proliferation *in vivo*. To conclude, our results point to a pivotal role of pancreatic pericytes in neonatal β-cell proliferation.

2. Materials and methods {#sec2}
========================

2.1. Mice {#sec2.1}
---------

Mice were maintained according to protocols approved by the Institutional Animal Care and Use Committee at Tel Aviv University. All mice were maintained on a C57BL/6 background. Nkx3.2-Cre (Nkx3-2^tm1(cre)Wez^) [@bib39] mice were a generous gift from Warren Zimmer (Texas A&M). *R26*-YFP (Gt(ROSA)26Sor^tm1(EYFP)Cos^) [@bib40] and iDTR (Gt(ROSA)26Sor^tm1(HBEGF)Awai^) [@bib38] mice were obtained from Jackson Laboratories. Wild-type mice were purchased from Envigo, Ltd. When indicated, mice were i.p. injected with a single dose of 0.25 ng/g body weight Diphtheria Toxin (DT; List) diluted in PBS.

2.2. Islet isolation {#sec2.2}
--------------------

Collagenase P (0.8 mg/ml; Roche) diluted in RPMI (Gibco) was injected through the common bile duct into the pancreas of a euthanized adult mouse. Dissected pancreatic tissue was incubated for 10--15 min at 37 °C, followed by a gradient separation with Histopaque 1119 (Sigma) for 20 min at 4 °C. Islets were collected from the gradient interface, followed by their manual collection.

2.3. Flow-cytometry {#sec2.3}
-------------------

For cell sorting, dissected pancreatic tissues were digested with 0.4 mg/ml collagenase P (Roche) and 0.1 ng/ml DNase (Sigma) diluted in HBSS for 30 min at 37 °C with agitation, followed by cell filtration [@bib41]. Cells were suspended in PBS containing 5% FCS and 5 mM EDTA and sorted based on their yellow fluorescence by FACS Aria (BD). For staining of cell surface markers, cells were isolated as described above and stained with biotin-conjugated anti-PDGFRβ (Platelet-derived Growth Factor Receptor β) antibody (Catalog \#13-1402, Affymetrix) followed by incubation with Allophycocyanin-labeled Streptavidin (Catalog \#17-4317-82, Affymetrix). Cells were analyzed by a Gallios cytometer (Beckman Coulter) using Kaluza software (Beckman Coulter). For analysis of cell proliferation, single-cell suspension was obtained by incubating islets with 0.05% Trypsin and 0.02% EDTA solution (Biological Industries) at 37 °C for 5 min with agitation, or by collecting βTC-tet cells with 0.05% Trypsin and 0.02% EDTA solution (Biological Industries). Cells were fixed in 70% ethanol at −20 °C overnight, suspended in PBS containing 1--2% FBS and 0.09% sodium azide, and then immunostained with Fluorescein-conjugated anti-Ki67 (Catalog \#11-5698-82, eBioscience or Catalog \#556026, BD) antibody. Islet cells were further stained with guinea pig anti-insulin (Catalog \#A0564, Dako) antibody, followed by DyLight 650-conjugated secondary antibody (SA5-10097, Invitrogen). For analyzing proliferation rates, cells were analyzed by a FACS Gallios cytometer (Beckman Coulter) using Kaluza software (Beckman Coulter). For cell counting, cells were analyzed by an Accuri C6 cytometer (BD) using its volumetric counting feature.

2.4. Cell culture {#sec2.4}
-----------------

For culturing pericytes, at least 1.5 × 10^5^ sorted cells were cultured in DMEM medium (Gibco) containing 10% FCS (Hyclone), 1% [l]{.smallcaps}-Glutamine (Biological Industries) and 1% Penicillin-Streptomycin solution (Biological Industries) ('complete DMEM'). Cells were sub-cultured weekly or when about 90% confluent, using 0.25% Trypsin solution with 0.05% EDTA (Biological Industries). Up to their third passage, cells were plated on collagen-coated plates (Catalog \#FAL354236, Corning). Media were collected from cells in their fourth passage, passed through a 22 μm filter to exclude cells, supplemented with proteases inhibitor (Roche), and then stored at −80 °C. Islets and βTC-tet cells were grown in complete DMEM. Growth arrest of βTC-tet cells was induced by supplementing culture medium with 1 μg/ml tetracycline (Sigma) for 10 days before a proliferation assay was performed [@bib37], [@bib42]. For heat inactivation, pericyte-conditioned medium and complete DMEM were incubated at 62 °C for 20 min. For blocking of β1 integrin signaling, pericyte-conditioned medium was supplemented with either hamster anti-β1 integrin (CD29) antibody (Catalog \#555003, BD) or hamster IgM (Catalog \#553958, BD) as a control. Cultured pericytes were imaged using a Nikon Eclipse Ti-E epifluorescence inverted microscope.

2.5. Immunofluorescence and morphometric analyses {#sec2.5}
-------------------------------------------------

Dissected pancreatic tissues were fixed in 4% paraformaldehyde for 4 h. Tissue was transferred to 30% sucrose solution overnight at 4 °C, followed by embedding in Optimal Cutting Temperature compound (OCT, Tissue-Tek) and cryopreservation. 11-μm-thick tissue sections were stained with the following primary antibodies: guinea pig anti-insulin (Catalog \#A0564, Dako), rabbit anti- αSMA (α smooth muscle actin; Catalog \#Ab5694, Abcam), Ki67 (Catalog \#RM-9106, Thermo Scientific), and NG2 (Neural Glial antigen 2; Catalog \#AB5320, Millipore), and rat anti-PECAM1 (Platelet endothelial cell adhesion molecule 1; Catalog \#553370, BD) antibodies, followed by secondary fluorescent antibodies (AlexaFluor, Invitrogen). For TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assays, the Fluorescein In Situ Cell Death Detection Kit (Roche) was used according to manufacturer\'s protocol. Stained sections were mounted using Vectashield antifade mounting medium with DAPI (Vector). Images were acquired using an SP8 confocal microscope (Leica) or a Keyence BZ-9000 microscope (Biorevo). For analysis of islet endothelial and pericyte coverage, sections at least 50 μm apart were stained as described. Islets were defined as insulin^+^ areas. NG2^+^ or PECAM1^+^ areas within the islets, as well as insulin^+^ areas, were measured using ImageJ software (NIH). For cell proliferation analysis, sections at least 50 μm apart were stained as described. Images were analyzed manually blind to genotype; at least 300 insulin^+^ cells were analyzed for each pup.

2.6. Statistical analysis {#sec2.6}
-------------------------

Paired data were evaluated using Student\'s two-tailed *t*-test.

3. Results {#sec3}
==========

3.1. Culturing neonatal pancreatic pericytes {#sec3.1}
--------------------------------------------

In order to test the ability of neonatal pancreatic pericytes to promote β-cell replication *in vitro*, we set out to isolate and culture them. To this end, we sorted YFP-labeled cells from the pancreas of *Nkx3.2*-Cre;*R26*-YFP pups at postnatal day 5 (p5). During development, *Nkx3.2* (*Bapx1*) is expressed in gut, stomach, and pancreatic mesenchyme, as well as in skeletal somites [@bib43], [@bib44]. In the embryonic and adult pancreas, the *Nkx3.2*-Cre mouse line specifically targets mesenchymal cells, which, in the adult, consist of pericytes and vSMCs [@bib27], [@bib33], [@bib36], [@bib41]. To determine if the *Nkx3.2*-Cre mouse line targets pancreatic pericytes at the neonatal age, as in adults, we analyzed fluorescently labeled ('Nkx3.2/YFP^+^') cells of p5 *Nkx3.2*-Cre;*R26*-YFP pancreatic tissue for PDGFRβ, which is expressed on the surface of pericytes but not on that of vSMCs [@bib27]. As shown in [Figure 1](#fig1){ref-type="fig"}A, our flow-cytometry analysis revealed that ∼90% of Nkx3.2/YFP^+^ cells in the p5 pancreas express PDGFRβ, displaying their pericytic identity. PDGFRβ-negative Nkx3.2/YFP^+^ cells represent vSMCs, which are targeted by the *Nkx3.2*-Cre mouse line but do not express this receptor [@bib27], [@bib36]. To conclude, our results indicate that the *Nkx3.2*-Cre mouse line efficiently targets pericytes in the neonatal pancreas.Figure 1**Culturing neonatal pancreatic pericytes**. **A**) Flow-cytometry analysis of digested pancreatic tissue. *Left*, Dotplot showing the presence of a yellow fluorescent cell population (gated green cells; 'Nkx3.2/YFP^+^ cells') in the pancreas of *Nkx3.2*-Cre;*R26*-YFP at postnatal day 5 (p5). *Right*, Green histogram ('+Primary antibody') showing the staining of Nkx3.2/YFP^+^ cells (as gated in left panel) for the pericytic marker PDGFRβ. Gray histogram showing the analysis of Nkx3.2/YFP^+^ cells without the addition of the primary antibody ('Staining control'). The number represents the percentage of PDGFRβ-stained cells from the total Nkx3.2/YFP^+^ cell population (as indicated by a horizontal line). Note that the vast majority of Nkx3.2/YFP^+^ cells express this pericytes\' marker. **B**) Schematic illustration of cultured neonatal pancreatic pericytes. Pancreatic tissues of *Nkx3.2*-Cre;*R26*-YFP p5 pups were dissected and digested to obtain a single cell suspension. Pericytes were FACS sorted based on their yellow fluorescence (as shown in A′, Nkx3.2/YFP^+^ cells), and cultured in complete DMEM medium. During the cells\' fourth passage, their conditioned media were collected. **C**) Cultured neonatal pancreatic pericytes. A yellow fluorescent image (showed in green for easier visualization) overlaid on top of a brightfield image of cultured Nkx3.2/YFP^+^ cells (as described in B′) during their fourth passage. Representative field is shown. Note extension of cytoplasmic process by cultured cells.Figure 1

Next, pericytes from neonatal pancreatic tissue were isolated and cultured to collect their conditioned media. To culture pericytes, dissected pancreatic tissues of p5 *Nkx3.2*-Cre;*R26*-YFP pups were digested to obtain single cells, followed by sorting of Nkx3.2/YFP^+^ cells by fluorescence-activated cell sorting (FACS) and culturing of sorted cells (Illustrated in [Figure 1](#fig1){ref-type="fig"}B). Yellow fluorescence of cultures cells verified they were indeed sorted Nkx3.2/YFP^+^ pericytes ([Figure 1](#fig1){ref-type="fig"}C). Furthermore, all cultured cells extended cytoplasmic processes typical to pericytes. After four passages, the cell-conditioned medium was collected and filtered to exclude cells (illustrated in [Figure 1](#fig1){ref-type="fig"}B).

3.2. Pericyte-conditioned medium stimulates β-cell proliferation *in vitro* {#sec3.2}
---------------------------------------------------------------------------

To analyze the effect of neonatal pericyte-conditioned medium on β-cell proliferation *in vitro*, we analyzed the response of both the β-cell line βTC-tet and primary mouse adult β-cells to this medium. Immortalization of βTC-tet cells was achieved through conditional expression of SV40 (Simian Vacuolating Virus 40) large T-antigen under the control of rat *Ins2* promoter [@bib37], [@bib42]. The expression of the T-antigen under the tetracycline operon regulatory system (tet) allows for its shut-off upon exposure to tetracycline. Thus, in the presence of this antibiotic, the proliferation of βTC-tet cells becomes dependent on extrinsic factors [@bib42], [@bib45]. To test the ability of neonatal pericyte-conditioned medium to promote proliferation of βTC-tet cells, we incubated tetracycline-treated cells with this medium. To assess the level of cell proliferation, cells were stained for the proliferative marker Ki67 and analyzed by flow-cytometry. As shown in [Figure 2](#fig2){ref-type="fig"}A, exposure to pericyte-conditioned medium promoted the proliferation of about a third of the analyzed βTC-tet cells.Figure 2**Increased β-cell proliferation upon exposure to pericyte-conditioned medium**. **A**) Tetracycline-treated βTC-tet cells were cultured in either control (complete DMEM; 'Control medium') or neonatal pericyte-conditioned ('Conditioned medium'; described in [Figure 1](#fig1){ref-type="fig"}B) medium, both supplemented with tetracycline. After incubation for 96 h, cells were fixed and stained for the proliferative marker Ki67. *Left*, representative dotplots showing flow-cytometry analysis of Ki67 expression by βTC-tet cells. Gated are Ki67^+^ cells; the numbers represent the percentage of gated cells out of the analyzed cell population. *Right*, Bar diagrams (mean ± SD) represent the percentage of Ki67^+^ cells. N = 3. \*\*\*P \< 0.005 (Student\'s *t*-test), as compared to the control medium. A representative of three independent experiments is shown. **B**) Isolated islets from 3-month-old wild-type mice were cultured in either control (complete DMEM; 'Control medium') or neonatal pericyte-conditioned ('Conditioned medium'; described in [Figure 1](#fig1){ref-type="fig"}B) medium for 24 h. Islets were dispersed to single cells, fixed, and stained for insulin and the proliferative marker Ki67. *Left*, representative dotplots showing flow-cytometry analysis of Ki67 expression by insulin^+^ cells. Gated are Ki67^+^ cells; the numbers represent the percentage of gated cells out of the total insulin^+^ cell population. *Right*, Bar diagrams (mean ± SD) represent the percentage of Ki67^+^ out of the total number of insulin^+^ cells. N = 4. \*\*\*P \< 0.005 (Student\'s *t*-test), as compared to the control media. A representative of four independent experiments is shown. **C**) Isolated islets were cultured as described in B′ for 72 h. Islets were dispersed to single cells, fixed and stained for insulin. Bar diagrams (mean ± SD) represent the relative number of insulin^+^ cells, normalized to islets incubated with control medium. N = 3--4. \*P \< 0.05 (Student\'s *t*-test). **D**) Control (complete DMEM) and neonatal pericyte-conditioned ('conditioned medium'; as described in [Figure 1](#fig1){ref-type="fig"}B) medium were heated to 62 °C for 20 min. Isolated islets from 3-month-old wild-type mice were cultured in heated media for 24 h. Islets were dispersed to single cells, fixed and stained for insulin and the proliferative marker Ki67. Bar diagrams (mean ± SD) represent the percentage of Ki67^+^ out of the total number of insulin^+^ cells (gated as shown in B′). N = 3--4. NS = non-significant (Student\'s *t*-test). **E**) Tetracycline-treated βTC-tet cells were incubated with control (complete DMEM; tetracycline-supplemented) medium or neonatal pericyte-conditioned medium ('Conditioned medium', tetracycline-supplemented) for 96 h. The conditioned medium was supplemented with either anti-β1 integrin blocking antibody ('Anti-β1 integrin') or control IgM. Bar diagrams (mean ± SD) represent the relative cell number, normalized to cells incubated with control medium. N = 3. \*P \< 0.05, \*\*\*P \< 0.005, NS = non-significant (Student\'s *t*-test).Figure 2

Next, we analyzed the ability of the pericyte-conditioned media to promote proliferation of primary cultured adult β-cells. To this end, islets were isolated from 3-month-old mice and cultured in either control or pericyte-conditioned medium. To assess the level of β-cell proliferation, islet cells were dispersed and stained with antibodies against insulin and Ki67, and analyzed by flow-cytometry. As shown in [Figure 2](#fig2){ref-type="fig"}B, whereas less than 1% of β-cells cultured in control medium express Ki67, an average of 40% of cells incubated in the presence of pericyte-conditioned medium proliferated. Next, we analyzed for a potential effect on β-cell number. As shown in [Figure 2](#fig2){ref-type="fig"}C, the number of β-cells in islets cultured for 72 h in pericyte-conditioned medium was double the number in islets cultured in control medium. Thus, our results indicate that factors secreted by cultured pancreatic pericytes stimulate proliferation of both a β-cell line and primary cultured adult β-cells.

Extracellular matrix (ECM) components, including these found in islets vascular BM, were shown to promote β-cell proliferation [@bib20], [@bib28], [@bib46], [@bib47]. We thus analyzed the contribution of these factors to β-cell proliferation stimulated by pericyte-conditioned medium. First, we analyzed if proliferation of primary β-cells depends on heat-sensitive components (such as proteins) of the medium. Heating the conditioned medium (to 62 °C) prior to islet culture resulted in a low β-cell proliferation rate, which was comparable to their culturing with control media ([Figure 2](#fig2){ref-type="fig"}D). This result indicates that pericytes produce heat-sensitive factors, such as BM components and other proteins, to promote β-cell expansion. BM components are recognized by integrins and initiate downstream signaling, and integrins containing the β1 chain were shown to mediate β-cell proliferation [@bib20], [@bib28]. To analyze the contribution of β1 integrin signaling to pericyte-mediated β-cell proliferation, we inhibited it in βTC-tet cells. To this end, we supplemented the pericyte-conditioned medium with a specific anti-β1 integrin blocking antibody. As shown in [Figure 2](#fig2){ref-type="fig"}E, blocking β1 integrin signaling inhibited the expansion of βTC-tet cells cultured in pericyte-conditioned medium. Of note, βTC-tet cell number after their culturing in pericyte-conditioned medium supplemented with anti-β1 integrin blocking antibody was comparable to the number of cells cultured in control medium ([Figure 2](#fig2){ref-type="fig"}E). Thus, our analysis indicated that neonatal pancreatic pericytes stimulate β-cell proliferation in a β1 integrin-dependent manner.

To conclude, our analysis indicated that neonatal pancreatic pericytes secrete factors that promote β-cell proliferation.

3.3. Diphtheria toxin-mediated depletion of neonatal pancreatic pericytes {#sec3.3}
-------------------------------------------------------------------------

To analyze the *in vivo* role of neonatal pancreatic pericytes, we set out to deplete this cell population using the Diphtheria Toxin Receptor (DTR) system. To deplete pericytes, we generated *Nkx3.2*-Cre;iDTR mice, which express DTR in a Cre-dependent manner [@bib36]. Cell-specific expression of the iDTR transgene, combined with DT administration, serves as a tool for targeted cell ablation [@bib48], [@bib49]. We have previously used this system to deplete mesenchymal cells from the embryonic pancreas [@bib33], as well as pericytes from the adult pancreas [@bib36] in *Nkx3.2*-Cre;iDTR mice. To deplete pericytes in neonatal pancreas, *Nkx3.2*-Cre;iDTR pups as well as control littermates (iDTR-transgenic pups, which do not express -Cre) at p3 were i.p. injected with DT ([Figure 3](#fig3){ref-type="fig"}A). In addition to its pancreatic expression, the *Nkx3.2*-Cre line also displays non-pancreatic expression in the joints and gastro-intestinal mesenchyme [@bib39], [@bib50]. Treating neonatal mice with the DT dose used for treating adult mice (4 ng/gr body weight [@bib36]) attenuated the growth and survival of *Nkx3.2*-Cre;iDTR transgenic pups. Therefore, we titered the dose of injected DT to ensure that the growth of the pups would be unaffected by the treatment. Our results indicated that injecting p3 *Nkx3.2*-Cre;iDTR pups with 0.25 ng/gr body weight DT allowed them to grow normally, as manifested by a body weight comparable to their control littermates at ages p5 and p21 ([Figure 3](#fig3){ref-type="fig"}B), and their long-term survival. This indicates that weight gain and growth were unaffected in DT-treated *Nkx3.2*-Cre;iDTR pups.Figure 3**Partial depletion of pancreatic pericytes in DT-treated *Nkx3.2*-Cre;iDTR pups**. *Nkx3.2*-Cre;iDTR transgenic pups and littermate controls (carrying the iDTR transgene, but not the *Nkx3.2*-Cre transgene; 'Control \[iDTR\]') were i.p. injected with 0.25 ng/gr body weight DT at p3 and analyzed at p5 ('DT p3→p5') or p21 ('DT p3→p21'). **A**) Schematic illustration of mouse treatment. **B**) Bar diagram (mean ± SD) showing the relative body weight of DT-treated *Nkx3.2*-Cre;iDTR (empty bars) and control (black bars, set to '1') littermates at p5 and p21. n = 5. **C**) Pancreatic tissues of DT-treated p5 *Nkx3.2*-Cre;iDTR (right) and control (left) mice were stained for NG2 (red) to label pericytes, PECAM1 (green) to label endothelial cells, and insulin to label β-cells. White lines demarcate the outer border of the insulin^+^ area. Note that all capillaries in control islets contained both endothelial cells and pericytes, whereas some capillaries in *Nkx3.2*-Cre;iDTR islets contained only endothelial cells. Representative fields are shown. The same imaging parameters were used to analyze *Nkx3.2*-Cre;iDTR and control tissues. **D**, **E**) Bar diagrams (mean ± SD) showing decreased intra-islet pericyte density (D), but not endothelial density (E), in DT-treated p5 *Nkx3.2*-Cre;iDTR mice (empty bars) compared with a control (black bars, set to '1'). Pancreatic tissues were stained as described in C\', and the relative ratio of NG2^+^ or PECAM1^+^, and the Insulin^+^ area for each islet was calculated. At least 30 islets per mouse, from sections at least 50 μm apart, were analyzed. N = 3. \*\*\*, P \< 0.005 (Student\'s *t*-test), as compared to control littermates. **F**) Pancreatic tissues of DT-treated p5 *Nkx3.2*-Cre;iDTR (right) and control (left) mice were stained for αSMA (red) to label vSMCs, and PECAM1 (green) to label endothelial cells. Representative fields are shown. The same imaging parameters were used to analyze *Nkx3.2*-Cre;iDTR and control tissues.Figure 3

To assess pericyte depletion, we measured islet pericyte and endothelial coverage for pups at p5. Our morphometric analysis revealed that DT treatment of *Nkx3.2*-Cre;iDTR pups led to ∼25% reduction in islet pericyte coverage, identified by the expression of the pericytic marker NG2 ([Figure 3](#fig3){ref-type="fig"}C,D) [@bib27]. In contrast, islet coverage by endothelial cells, identified by the expression of PECAM1, remained unchanged ([Figure 3](#fig3){ref-type="fig"}C,E). Notably, we did not observe gross changes in the coverage of large pancreatic vessels by vSMCs (identified by the expression of high αSMA levels; [Figure 3](#fig3){ref-type="fig"}F) in DT-treated *Nkx3.2*-Cre;iDTR pups as compared to control. Thus, treatment of *Nkx3.2*-Cre;iDTR pups with a low DT dose allows partial, but specific, depletion of their islet pericytes without affecting their growth.

3.4. Depletion of neonatal pancreatic pericytes impairs β-cell proliferation *in vivo* {#sec3.4}
--------------------------------------------------------------------------------------

To determine whether neonatal pancreatic pericytes are required for β-cell proliferation, we depleted pancreatic pericytes by treating *Nkx3.2*-Cre;iDTR pups with DT. Determining primary, rather than secondary effects requires studying short-term events. Therefore, *Nkx3.2*-Cre;iDTR pups and control (iDTR-transgenic pups, which do not express Cre) littermates were treated with 0.25 ng/gr body weight DT at p3 and analyzed 2 days after DT administration, at p5. To analyze the effect of pericyte depletion on β-cell proliferation, we measured the percentage of Ki67^+^ cells out of the total number of insulin-expressing cells in pancreatic tissues of DT-treated *Nkx3.2*-Cre;iDTR and control pups by immunofluorescence ([Figure 4](#fig4){ref-type="fig"}A). Our morphometric analysis indicated a significant reduction of the portion of proliferating β-cells in DT-treated *Nkx3.2*-Cre;iDTR mice to about two thirds of that observed in littermate controls ([Figure 4](#fig4){ref-type="fig"}A).Figure 4**Reduced neonatal β-cell proliferation rates upon pericyte depletion**. *Nkx3.2*-Cre;iDTR transgenic pups and littermate controls (carrying the iDTR transgene, but not the *Nkx3.2*-Cre transgene; 'Control \[iDTR\]') were i.p. injected with 0.25 ng/gr body weight DT at p3 and analyzed at p5 ('DT p3→p5'). **A**) Pancreatic tissues were stained for insulin to label β-cells (red) and Ki67 (green) to mark proliferative cells. *Left*, representative fields showing immunofluorescence analysis of Ki67 and insulin. *Right*, Bar diagrams (mean ± SD) represent the percentage of Ki67^+^ cells out of the total number of insulin^+^ cells in DT-treated p5 *Nkx3.2*-Cre;iDTR mice (empty bars) compared with control (black bars, set to '1'), stained as shown in left panels. At least 300 insulin^+^ cells were analyzed for each mouse. The same imaging parameters were used to analyze *Nkx3.2*-Cre;iDTR and control tissues. N = 3. \*\*\*P \< 0.005 (Student\'s *t*-test). **B**) Pancreatic tissues of DT-treated p5 *Nkx3.2*-Cre;iDTR (middle panel) and control (left panel) were subjected to TUNEL assay (green) to identify dying cells, and were stained for insulin (red) to identify β-cells. The right panel shows similarly stained non-transgenic pancreatic tissue pre-treated with DNase to induce DNA breaks, which served as a positive control for the TUNEL assays ('staining control'). Representative fields are shown. The same imaging parameters were used to analyze *Nkx3.2*-Cre;iDTR and control tissues.Figure 4

The observed reduced β-cell proliferation may result from the impaired survival of these cells. We therefore performed TUNEL assays on pancreatic tissue sections from DT-treated *Nkx3.2*-Cre;iDTR and control p5 pups to analyze for potential β-cell apoptosis. Our analysis did not indicate β-cell death upon pericyte depletion ([Figure 4](#fig4){ref-type="fig"}B).

To conclude, our results indicate that reduced pericyte density impairs β-cell proliferation *in vivo*, indicating that pancreatic pericytes are required for neonatal β-cell expansion.

4. Discussion {#sec4}
=============

In this study, we provided evidence that pancreatic pericytes play a critical role in promoting the proliferation of neonatal β-cells. Our findings indicate that factors secreted by pericytes isolated from neonatal pancreatic tissue stimulated β-cell proliferation *in vitro*. Furthermore, we show that this proliferation requires β1 integrin signaling, implicating the involvement of BM components. Finally, we showed an impaired neonatal β-cell proliferation upon depletion of pancreatic pericytes *in vivo*. Thus, our findings highlight the requirement of the pericyte/β-cell axis in establishing β-cell mass.

Islets are encased within the peri-islet BM and associated interstitial matrix, which contains multiple ECM components [@bib26]. Interestingly, β-cells do not produce their own BM, but rather, rely on ECM components deposited into their niche by other cells, including endothelial cells [@bib20]. The vascular BM, located within and around islets, was shown to support β-cell function and proliferation [@bib20], [@bib28]. Heterotypic interactions of pericytes and endothelial cells are required for vascular BM assembly in many tissues [@bib27] and likely play a similar role in the pancreas. We recently showed that the embryonic and neonatal pancreatic mesenchyme produces laminins along with other BM components [@bib51]. Here, we show that inhibiting β-cells\' ability to respond to these cues, by blocking β1 integrin signaling, attenuates their pericyte-dependent proliferation. Our analysis therefore links β-cell proliferation to the production of BM components by pancreatic pericytes.

In addition to ECM components, β-cell proliferation was shown to be induced by an array of secreted growth factors [@bib52]. Others and we reported that the embryonic pancreatic mesenchyme expresses a number of growth factors implicated in β-cell proliferation, including IGF1 (Insulin Growth Factor 1), TGFβ2 (Transforming Growth Factor β 2), TGFβ3, HGF (Hepatocyte Growth Factor), and PDGF [@bib10], [@bib30], [@bib34], [@bib52], [@bib53], [@bib54]. Since these analyses were performed during embryogenesis, it would be of interest to determine whether pancreatic pericytes express growth factors after birth to promote neonatal β-cell expansion.

The low β-cell proliferation rate during adulthood [@bib9] could suggest that pericytes do not support β-cell proliferation after the neonatal period. Our analysis indicates that in culture, neonatal pericytes can stimulate adult β-cell proliferation. Thus, β-cells maintain their ability to respond to proliferative cues produced by pericytes even as they age. It is therefore possible that age-dependent changes in pancreatic pericytes affect their ability to promote β-cell proliferation beyond the neonatal period. Alternatively, physiological levels of pericytic components might be insufficient to drive adult β-cell proliferation *in vivo*.

β-cell mass is reduced in both Type 1 and Type 2 diabetes mellitus [@bib9], [@bib55]. Thus, β-cell regeneration and replacement represent attractive approaches for treating this disease. Since both approaches rely on cell proliferation, elucidating and harnessing the regulatory mechanism underlying physiological β-cell proliferation will facilitate establishing protocols for β-cell expansion. Here, we suggest a previously unappreciated role of a key component of the pancreas microenvironment, namely, pericytes, in neonatal β-cell replication. The findings of this study would therefore aid in developing improved protocols for β-cell expansion as a potential cure for diabetes.
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